Glutathione status and the incidence of neural tube defects elicited by direct acting teratogens in vitro.
Valproic acid (VPA), cytochalasin D (CD) and 7-hydroxy-2-acetylaminofluorene (7-OH-AAF) each caused abnormal closure of the anterior neuropore in rat embryos cultured in vitro in the absence of an exogenous bioactivation system. Morphological comparisons showed that although all three compounds prevented normal neural tube closure, each did so in a distinctive manner. Modulation of GSH in cultured rat conceptuses was evaluated to determine whether common responses occurred relative to the ability of different chemicals to elicit neural tube defects. Malformation incidence in embryos (10-14 somites) varied widely following exposure to CD (44%), 7-OH-AAF (29%) or VPA (17%). The incidence of CD-elicited malformations was increased by 50% following GSH depletion by L-buthionine-S, R-sulfoximine (BSO) and was decreased by nearly 60% when the cysteine pro-drug 2-oxothiazolidine-4-carboxylate (OTC) was added to the culture medium. GSH modulation also exerted significant effects on the incidence of abnormal neurulation caused by VPA or 7-OH-AAF. A relatively low incidence of open neural tubes produced by VPA or 7-OH-AAF alone was shown to be a function of the state of maturation in the embryos. Conceptuses cultured in the presence of VPA or 7-OH-AAF from an earlier gestational age (6-10 somites) showed 2-3 fold increases in the number of embryos with open neural tubes. Differential alterations in protein and DNA content were observed among embryos and yolk sacs after various treatments indicating possible differences in the site of embryotoxicity. These results demonstrate the role of GSH status on the capacity of three chemically diverse compounds to elicit abnormal neurulation in cultured rat embryos and suggest some possible mechanisms by which normal neurulation may be compromised.
D015073:2-Acetylaminofluorene / Q000031:analogs & derivatives*; D000818:Animals; D015638:Cytochalasin D; D003572:Cytochalasins / Q000633:toxicity*; D005260:Female; D005978:Glutathione / Q000494:pharmacology*; D006881:Hydroxyacetylaminofluorene / Q000633:toxicity*; D009436:Neural Tube Defects / Q000139:chemically induced* / Q000473:pathology; D009924:Organ Culture Techniques; D011247:Pregnancy; D051381:Rats; D011919:Rats, Inbred Strains; D012016:Reference Values; D013723:Teratogens; D014635:Valproic Acid / Q000633:toxicity*
D003572:Cytochalasins; D013723:Teratogens; D015638:Cytochalasin D; D006881:Hydroxyacetylaminofluorene; D014635:Valproic Acid; D015073:2-Acetylaminofluorene; D005978:Glutathione